NCT02440178View on ClinicalTrials.gov

Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia

PHASE2CompletedINTERVENTIONAL

Enrollment

66

Participants

Timeline

Start Date

September 19, 2015

Primary Completion Date

June 1, 2017

Study Completion Date

June 1, 2017

Conditions

Acute Leukemia

Interventions

DRUG

Micafungin

Sponsors

Collaborators (1)

Astellas Pharma Inc

All Listed Sponsors

collaborator

Astellas Pharma Inc

INDUSTRY

lead

Seoul National University Hospital

OTHER